
Kerem Ozer MD
Diabetes, Lipid Metabolism
MD Texas Diabetes & Endocrinology
Join to view full profile
110 Deer Ridge DrRound Rock, TX 78681
Phone+1 512-458-8400
Fax+1 512-458-8593
Dr. Ozer is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Southwestern Medical CenterResidency, Gastroenterology, 2017 - 2023
Baylor College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2006 - 2009
Baylor College of MedicineResidency, Internal Medicine, 2003 - 2005
Istanbul University FomClass of 2002
Certifications & Licensure
MA State Medical License 2023 - 2028
TX State Medical License 2008 - 2028
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification e-MDs Solution Series, eMDs, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification e-MDs Solution Series, eMDs, 2012, 2014-2017
- Diabetes Recognition Program National Committee for Quality Assurance, 2013-2016
Clinical Trials
Publications & Presentations
PubMed
- 4 citationsImpact of Infusion Set Materials and Designs on the Subcutaneous Response in People With Diabetes: A Rapid Review of the Literature.Kristoffer Hendel, Tobias Stumpe, Kerem Ozer
Journal of Diabetes Science and Technology. 2023-03-01 - 56 citationsFlash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis.Anders L Carlson, Timothy Dilon Daniel, Andrea DeSantis, Serge Jabbour, Esra Karslioglu French
BMJ Open Diabetes Research & Care. 2022-01-01 - 31 citationsFast Acting Insulin Aspart Compared with Insulin Aspart in the Medtronic 670G Hybrid Closed Loop System in Type 1 Diabetes: An Open Label Crossover Study.Kerem Ozer, Alison M Cooper, Lily P Ahn, Cassidy R Waggonner, Thomas Blevins
Diabetes Technology & Therapeutics. 2021-03-22
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: